People | May 27, 2026
Ashish Mukkirwar appointed CFO of Jubilant Pharmova
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
The company highlighted continued demand strength and pricing resilience despite global disruptions
The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment
The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy
Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum
Transition to a fermentation-based globally integrated CDMO platform
Diagnostic-guided healthcare platform strengthens leadership team to accelerate AI-driven diagnostics and consumer healthcare expansion
Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth
Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance
Combined footprint expands to 420 hearing care centres across India
Subscribe To Our Newsletter & Stay Updated
